Charles River Laboratories | CRL - 税前利润

股票价格
175.73
每天变化
0.18 0.10%
每月一次
4.04%
每年
76.17%
Q2 预测
168.66


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.95B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


税前利润 更改 日
Agilent USD 442M 1000K 2025-09
Align Technology USD 176.6M 81.86M 2025-12
Bio-Rad Laboratories USD 82.9M 331.1M 2025-09
Bruker USD -72.6M 73.1M 2025-09
Cardinal Health USD 598M 214M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cigna USD 2.3B 274M 2025-09
CVS Health USD 1.35B 4.84B 2025-12
Danaher USD 1.08B 421M 2025-09
Dentsply International USD -230M 77M 2025-09
Elevance Health USD 215M 1.19B 2025-12
Galapagos EUR -221.49M 117.07M 2025-09
Hologic USD 229.7M 2.3M 2025-12
Humana USD 527M 214M 2025-09
Illumina USD 220M 86M 2025-09
Incyte USD 389.94M 92.37M 2025-12
Intrexon USD -60.48M 27.09M 2024-06
IQVIA Holdings USD 6.16B 5.84B 2025-09
Laboratory Of America USD 337M 32.3M 2025-09
Lonza CHF 624M 197M 2024-12
McKesson USD 1.4B 344M 2025-09
Merck EUR 1.29B 458.1M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Novartis USD 4.64B 445M 2025-12
Pfizer USD 3.33B 290M 2025-09
Quest Diagnostics USD 336M 57M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
United Therapeutics USD 444M 6M 2025-12
UnitedHealth USD 3.23B 1.16B 2025-09
Veradigm USD 35.3M 13.95M 2022-09
Waters USD 170.12M 7.57M 2025-09
West Pharmaceutical Services USD 170.1M 8.1M 2025-09